![Donald Nicholson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Nicholson
Président chez
DISC MEDICINE, INC.
Fortune : 1 M $ au 31/07/2026
Profil
Donald W.
Nicholson is currently Chief Executive Officer at Nimbus Apollo, Inc., Executive Chairman at NodThera Ltd., Disc Medicine Opco, Inc., and Disc Medicine, Inc., Independent Chairman at Muna Therapeutics ApS, Director at Matchpoint Therapeutics, Inc., Advisor at Atlas Venture Advisors, Inc., and Vice President at Merck Frost Centre For Therapeutic Research, Inc. Formerly, Dr. Nicholson was Chief Executive Officer & Director at Nimbus Therapeutics LLC from 2014 to 2018, Chairman at Jnana Therapeutics, Inc. from 2019 to 2024, Executive Chairman at Generation Bio Co. from 2025 to 2026, Executive Chairman at Gemini Therapeutics, Inc., Independent Director at Kymera Therapeutics, Inc. from 2017 to 2022, and Vice President & Head-San Diego Research Site at Merck & Co., Inc. Education includes undergraduate and doctorate degrees from the University of Western Ontario.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,04% | 18/06/2026 | 15 332 ( 0,04% ) | 1 M $ | 31/07/2026 |
Postes actifs de Donald Nicholson
| Sociétés | Poste | Début |
|---|---|---|
| DISC MEDICINE, INC. | Président | 01/04/2019 |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Directeur Général | - |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Président | 10/04/2019 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Président | 01/04/2019 |
Merck Frost Centre For Therapeutic Research, Inc. | Corporate Officer/Principal | - |
Muna Therapeutics ApS
 Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Président | 13/09/2021 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Matchpoint Therapeutics, Inc.
 Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Directeur/Membre du Conseil | 01/11/2022 |
Anciens postes connus de Donald Nicholson
| Sociétés | Poste | Fin |
|---|---|---|
| GENERATION BIO CO. | Président | 06/02/2026 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░ | - |
Formation de Donald Nicholson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Operates as a chemo proteomics platform to develop small molecule medicines | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Muna Therapeutics ApS
Muna Therapeutics ApS BiotechnologyHealth Technology Engages in discovering and developing of therapies that slow and stop devastating neurodegenerative, alzheimer’s & parkinson’s diseases | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Merck Frost Centre For Therapeutic Research, Inc. | |
Matchpoint Therapeutics, Inc.
Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company harnessing the power of covalency to discover precision covalent medicines | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
